<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://openbell.ai/</loc>
    <lastmod>2026-11-19T03:37:47.052Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://openbell.ai/support</loc>
    <lastmod>2026-11-19T03:37:47.052Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://openbell.ai/privacy</loc>
    <lastmod>2026-11-19T03:37:47.052Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/terms</loc>
    <lastmod>2026-11-19T03:37:47.052Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/feed.json</loc>
    <lastmod>2026-11-19T03:37:47.052Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://openbell.ai/news/REGN:1795057307000</loc>
    <lastmod>2026-11-19T03:01:47.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/REGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>FDA Approves Regeneron&#39;s Livsayis for Generalized Myasthenia Gravis</image:title>
      <image:caption>The FDA approved Regeneron Pharmaceuticals’ Livsayis (cemdisiran) for adults with generalized myasthenia gravis who test positive for anti-acetylcholine receptor antibodies. The C5-directed siRNA therapy is injected subcutaneously four times a year, a dosing frequency the company says is unique among gMG treatments, and approval was supported by Phase 3 NIMBLE trial results showing rapid, sustained disease control. Livsayis is Regeneron’s first approved siRNA therapy and its first neurology medicine; the article reports no financial figures or stock-price impact.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/INEO:1795050127000</loc>
    <lastmod>2026-11-19T01:02:07.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INEO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>INNEOVA Holdings Limited Reports Q3 2026 Financial Results and Strategic Expansion</image:title>
      <image:caption>INNEOVA Holdings reported record nine-month revenue of $53.59 million, up 17.6% year over year. In Q3, gross margin rose to 12.6%, up 465 basis points sequentially, and adjusted EBITDA improved about 18%; since year-end, total debt fell 34% and liabilities declined 18.2%, including settlement of an $8.0 million convertible note. The company entered Saudi Arabia through a five-year distribution agreement targeting an initial 126,000-unit order, expanded its Pharma Cell partnership in Albania, and signed a DIABIT-IS X commercialization agreement in Greece. By September 30, it had repurchased 255,600 shares under its $5.0 million buyback program.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/EPSM:1795050112000</loc>
    <lastmod>2026-11-19T01:01:52.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EPSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Epsium Enterprise Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026</image:title>
      <image:caption>Epsium Enterprise Limited reported first-half 2026 revenue of $1.47 million, down from $3.04 million a year earlier. Gross profit fell to $0.18 million from $0.50 million, and gross margin narrowed to 11.96% from 16.28%, reflecting a shift toward lower-margin fine wines and increased price competition. The operating loss widened to $0.75 million, while the net loss narrowed slightly to $0.67 million. Management cited weak demand and wholesale pricing for premium Chinese liquor in Macau; sales to gaming and hotel groups fell 46%.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ZKH:1795050108000</loc>
    <lastmod>2026-11-19T01:01:48.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ZKH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>ZKH Group Limited Announces Third Quarter 2026 Unaudited Financial Results</image:title>
      <image:caption>ZKH Group reported third-quarter 2026 revenue of RMB 2.75 billion, up 18.2% year over year, while GMV rose 24.1% to RMB 3.26 billion, its fastest growth pace since its IPO. The company posted its first quarterly operating profit, RMB 25.1 million, versus an operating loss of RMB 32.3 million a year earlier, and net profit of RMB 42.4 million compared with a net loss of RMB 24.3 million. ZKH also established AI subsidiary LingLong Intelligence and launched its industrial AI model, LingLong Insight 1.0.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/INLF:1795050105000</loc>
    <lastmod>2026-11-19T01:01:45.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INLF/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>INLIF Limited Advances Commercialization of Next-Generation Six-Axis Industrial Robots</image:title>
      <image:caption>INLIF Limited said its next-generation six-axis industrial robots have entered the market. Its wholly owned subsidiary, Ewatt Robot Equipment Co. Ltd., signed purchase and sales agreements with 10 partners in industrial automation integration and equipment manufacturing, with an expected combined contractual value exceeding US$10 million. INLIF plans to coordinate production, testing, and delivery against the agreements’ milestones and monitor fulfillment; the article reported no revenue, profit, or stock-price impact.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TGL:1795050104000</loc>
    <lastmod>2026-11-19T01:01:44.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Treasure Global Inc. Reports First Quarter Fiscal Year 2027 Financial Results</image:title>
      <image:caption>Treasure Global Inc. reported first-quarter fiscal 2027 revenue of US$2.21 million, up approximately 1,110% from US$182,527 a year earlier. The company returned to profitability, posting net income of US$1.78 million versus a US$2.13 million net loss in the prior-year quarter, while its operating loss narrowed approximately 25% to US$1.30 million. Management attributed the improvement to higher business activity and continued development of AI-enabled capabilities.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HIHO:1795050101000</loc>
    <lastmod>2026-11-19T01:01:41.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HIHO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Highway Holdings Reports Fiscal 2027 Second Quarter Financial Results</image:title>
      <image:caption>Highway Holdings reported fiscal 2027 second-quarter revenue of $2.44 million, up 107% year over year, and gross profit of $907,000, up 201%. Operating income was $10,000, compared with a $373,000 net loss in the year-earlier quarter. First-half net sales rose 62.7% to $4.44 million; management cited recovering customer activity and new business replacing volume lost during the downturn.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/KNDI:1795050092000</loc>
    <lastmod>2026-11-19T01:01:32.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KNDI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Kandi Technologies Reports Unaudited Financial Results for the Nine Months Ended September 30, 2026</image:title>
      <image:caption>Kandi Technologies reported nine-month 2026 revenue of $82.1 million, up 38.5% from $59.3 million a year earlier, driven mainly by off-road vehicle sales and contributions from Rawrr, acquired in February 2026. Gross profit increased 17.6% to $31.7 million, while gross margin fell to 38.6% from 45.5% amid product-mix changes; operating expenses declined 5.7% to $30.9 million. Its subsidiary China Battery Exchange also secured orders for 33 heavy-truck battery-swap stations from a CATL subsidiary.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/QQQ:1795048265706</loc>
    <lastmod>2026-11-19T00:31:05.706Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/QQQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Social Media Discussion: $QQQ</image:title>
      <image:caption>Bearish: Redditors warn that Anthropic’s IPO could leave 401(k) investors buying shares after private investors cash out. A full-time trader’s swing from a $10,000 month to breakeven highlights the instability of trading income.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NXAT:1795046514000</loc>
    <lastmod>2026-11-19T00:01:54.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NXAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Nexus Advanced Technologies Receives Nasdaq Staff Delisting Determination</image:title>
      <image:caption>Nexus Advanced Technologies (Nasdaq: NXAT) received a Nasdaq delisting determination on November 11, 2026, after its closing bid price stayed below $1.00 for 30 consecutive business days. Because it completed a 1-for-30 reverse stock split in August, the company is ineligible for the standard 180-day compliance period. Nexus plans to appeal and has requested a hearing, which will stay the trading suspension while the panel considers its case. Shareholders will vote at an extraordinary general meeting on December 28 on a proposal for another share consolidation.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MRM:1795046509000</loc>
    <lastmod>2026-11-19T00:01:49.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MRM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>MEDIROM Healthcare Technologies Inc. Receives Nasdaq Delisting Notice and Requests Hearing</image:title>
      <image:caption>MEDIROM Healthcare Technologies said Nasdaq notified it on November 13, 2026, that it had failed to file its 2025 Form 20-F within an extended deadline. Nasdaq indicated the company’s American Depositary Shares would face trading suspension and delisting beginning November 24. MEDIROM requested a hearing to appeal, automatically staying suspension for 15 days, and sought an extension through the hearing; it also remains out of compliance with Nasdaq’s minimum bid-price requirement.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SHAK:1795043007000</loc>
    <lastmod>2026-11-18T23:03:27.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SHAK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Starboard Value Reported to Acquire Shake Shack</image:title>
      <image:caption>Financial news reports on November 18, 2026, said Starboard Value is moving to acquire Shake Shack. The reports did not provide transaction terms, valuation, or confirmation that the deal had been finalized.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HP:1795042921000</loc>
    <lastmod>2026-11-18T23:02:01.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Helmerich &amp; Payne, Inc. Announces Fiscal Fourth Quarter and Fiscal 2026 Results</image:title>
      <image:caption>Helmerich &amp; Payne reported fiscal fourth-quarter revenue of $1.1 billion, up 6% sequentially, for the quarter ended September 30, 2026. It posted a net loss of $490 million, or $4.91 per share, primarily due to a $610 million non-cash impairment charge on Middle East assets. Adjusted earnings were $0.36 per share.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SNEX:1795042910000</loc>
    <lastmod>2026-11-18T23:01:50.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SNEX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>StoneX Group Inc. Reports Fiscal 2026 Fourth Quarter and Full Year Financial Results</image:title>
      <image:caption>StoneX Group reported record fiscal 2026 results, with full-year net operating revenues of $2.9 billion and net income of $525.4 million, up 72% year over year. Fourth-quarter net operating revenues rose 12% to $655.2 million, and diluted EPS was $0.66. CEO Philip Smith cited momentum across the Commercial, Institutional and Payments segments and the integration of the company’s largest acquisition to date. StoneX also completed three-for-two stock splits in March and July 2026.</image:caption>
    </image:image>
  </url>
</urlset>